Crossmark

Lecanemab bei früher Alzheimer-Krankheit zugelassen

Crossref DOI link: https://doi.org/10.1007/s15006-025-5026-0

Published Online: 2025-06-05

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Facharztmagazine, Redaktion
License Information

Text and Data Mining valid from 2025-06-01

Version of Record valid from 2025-06-01
More Information

Article History

First Online: 5 June 2025

Free to read: This content has been made available to all.